+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Therapy Media Market Size, Share & Trends Analysis Report by Product (Specialty Media, Serum-free Media), Vector Type (AAV, LV), End Use, and Region with Growth Forecasts, 2026-2033- Product Image
Gene Therapy Media Market Size, Share & Trends Analysis Report by Product (Specialty Media, Serum-free Media), Vector Type (AAV, LV), End Use, and Region with Growth Forecasts, 2026-2033- Product Image
New

Gene Therapy Media Market Size, Share & Trends Analysis Report by Product (Specialty Media, Serum-free Media), Vector Type (AAV, LV), End Use, and Region with Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • September 2025
  • Region: Global
  • Grand View Research
  • ID: 6176673
REQUEST CUSTOMIZATION
Description Jump to:
The global gene therapy media market size was estimated at USD 535.2 Million in 2025 and is projected to reach USD 1.61 billion by 2033, growing at a CAGR of 17.1% from 2026 to 2033. This growth is driven by increasing investments in gene therapy research, the rising prevalence of genetic disorders and chronic diseases, and the expanding pipeline of cell and gene-based therapies.

Strategic collaborations between biopharmaceutical companies and research institutions and favorable regulatory support for innovative therapies further contribute to the strong market outlook.

Growth in Rare Genetic Disease Therapies & Regulatory Support

One of the main factors propelling the gene therapy media industry is the growing emphasis on creating treatments for uncommon and orphan genetic illnesses. Millions of people worldwide suffer from more than 7,000 rare diseases, the majority of which do not yet have adequate therapies. The rising number of clinical trials targeting conditions such as spinal muscular atrophy, hemophilia, and inherited retinal disorders creates substantial demand for high-quality, consistent, scalable gene therapy media to support research and commercial manufacturing.

At the same time, regulatory agencies such as the U.S. FDA and the European Medicines Agency (EMA) are providing accelerated pathways, orphan drug designations, and incentives to encourage innovation in rare disease therapies. This supportive regulatory framework reduces time-to-market and increases investment and partnerships across the gene therapy ecosystem. The demand for robust, GMP-compliant media formulations is expected to rise as more therapies gain approval and enter the market, positioning gene therapy media as a vital component in advancing treatments for rare genetic diseases.

Increasing Capacity for Viral Vector Production

The expansion of viral vector production capabilities is a key driver of the gene therapy media market. As the number of gene therapy programs grows, manufacturers invest heavily in large-scale production facilities to meet the increasing demand for viral vectors, such as adeno-associated virus (AAV), lentivirus, and retrovirus. These vectors require highly specialized and optimized cell culture media to ensure high yield, consistency, and safety.

The shift from small-scale laboratory production to commercial-scale manufacturing necessitates media formulations that support robust cell growth, high transfection efficiency, and stable viral titers. The need for scalable, GMP-compliant viral vector production platforms and the specialized media that support them is anticipated to increase dramatically as more gene therapies move from clinical trials to commercialization. This is expected to directly contribute to the growth of the gene therapy media market.

Global Gene Therapy Media Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global gene therapy media market based on product, vector type, end use, and region:

Product Outlook (Revenue, USD Million, 2021-2033)

  • Specialty Media
  • Serum-free Media
  • Classical Media
  • Others

Vector Type Outlook (Revenue, USD Million, 2021-2033)

  • AAV Production
  • LV Production
  • Other Vectors

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical and Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs) & CROs
  • Research and Academic Institutes

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Vector Type
1.2.3. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Impact Analysis
3.3.1.1. Growth in rare genetic disease therapies and regulatory support
3.3.1.2. Increasing capacity for viral vector production
3.3.2. Market Restraint Impact Analysis
3.3.2.1. Technical and manufacturing challenges
3.3.2.2. Long development timelines
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. PORTER’S Five Forces Analysis
Chapter 4. Product Business Analysis
4.1. Product Segment Dashboard
4.2. Global Gene Therapy Media Market Product, Movement Analysis
4.3. Global Gene Therapy Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Specialty media
4.4.1. Global specialty media market estimates and forecasts, 2021-2033 (USD Million)
4.5. Serum-free Media
4.5.1. Global serum-free media market estimates and forecasts, 2021-2033 (USD Million)
4.6. Classical Media
4.6.1. Global classical media market estimates and forecasts, 2021-2033 (USD Million)
4.7. Others
4.7.1. Global other media market estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. Vector Type Business Analysis
5.1. Vector Type Segment Dashboard
5.2. Global Gene Therapy Media Market Vector Type, Movement Analysis
5.3. Global Gene Therapy Media Market Size & Trend Analysis, by Vector Type, 2021 to 2033 (USD Million)
5.4. AAV Production
5.4.1. Global AAV production market estimates and forecasts, 2021-2033 (USD Million)
5.5. LV Production
5.5.1. Global LV production market estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. End Use Business Analysis
6.1. End Use Segment Dashboard
6.2. Global Gene Therapy Media Market End User, Movement Analysis
6.3. Global Gene Therapy Media Market Size & Trend Analysis, by End User, 2021 to 2033 (USD Million)
6.4. Pharmaceutical and Biotechnology Companies
6.4.1. Global pharmaceutical and biotechnology companies market estimates and
6.5. Contract Development & Manufacturing Organizations (CDMOs) & CROs
6.5.1. Global contract development & manufacturing organizations (CDMOs) & CROs market estimates and forecasts, 2021-2033 (USD Million)
6.6. Research and Academic Institutes
6.6.1. Global research and academic institutes market estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. Gene Therapy Media Market: Regional Estimates and Trend Analysis, by Product, Vector Type, & End-Use
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
7.3. North America
7.3.1. North America gene therapy media market, 2021-2033 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. Gene therapy media market, 2021-2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Canada gene therapy media market, 2021-2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Mexico gene therapy media market, 2021-2033 (USD Million)
7.4. Europe
7.4.1. Europe gene therapy media market, 2021-2033 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. UK gene therapy media market, 2021-2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Germany gene therapy media market, 2021-2033 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. France gene therapy media market, 2021-2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Italy gene therapy media market, 2021-2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Spain gene therapy media market, 2021-2033 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Denmark gene therapy media market, 2021-2033 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Sweden gene therapy media market, 2021-2033 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Framework
7.4.9.4. Norway gene therapy media market, 2021-2033 (USD Million)
7.5. Asia-Pacific
7.5.1. Asia-Pacific gene therapy media market, 2021-2033 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Japan gene therapy media market, 2021-2033 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. China gene therapy media market, 2021-2033 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. India gene therapy media market, 2021-2033 (USD Million)
7.5.5. Japan
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Singapore gene therapy media market, 2021-2033 (USD Million)
7.5.6. Australia
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Australia gene therapy media market, 2021-2033 (USD Million)
7.5.7. Thailand
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Thailand gene therapy media market, 2021-2033 (USD Million)
7.5.8. South Korea
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. South Korea gene therapy media market, 2021-2033 (USD Million)
7.6. Latin America
7.6.1. Latin America gene therapy media market, 2021-2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Brazil gene therapy media market, 2021-2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Argentina gene therapy media market, 2021-2033 (USD Million)
7.7. MEA
7.7.1. MEA gene therapy media market, 2021-2033 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. South Africa gene therapy media market, 2021-2033 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Saudi Arabia gene therapy media market, 2021-2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. UAE gene therapy media market, 2021-2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Kuwait gene therapy media market, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2025
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck KGaA
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Sartorius AG
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Lonza
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Danaher Corporation (Cytiva)
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. FUJIFILM Holdings Corporation
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. MP Biomedicals
8.4.7.1. Overview
8.4.7.2. Product Benchmarking
8.4.7.3. Strategic Initiatives
8.4.8. Corning Incorporated
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. PAN-Biotech
8.4.9.1. Overview
8.4.9.2. Product Benchmarking
8.4.9.3. Strategic Initiatives
8.4.10. Bio-Techne (R&D Systems, Inc.)
8.4.10.1. Overview
8.4.10.2. Product Benchmarking
8.4.10.3. Strategic Initiatives
8.4.11. InVitria Inc
8.4.11.1. Overview
8.4.11.2. Product Benchmarking
8.4.11.3. Strategic Initiatives
8.4.12. Florabio aS
8.4.12.1. Overview
8.4.12.2. Product Benchmarking
8.4.12.3. Strategic Initiatives
8.4.13. Revvity
8.4.13.1. Overview
8.4.13.2. Product Benchmarking
8.4.13.3. Strategic Initiatives
8.4.14. Virica
8.4.14.1. Overview
8.4.14.2. Product Benchmarking
8.4.14.3. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 4. Global Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 5. Global Gene Therapy Media Market, End use, 2021-2033 (USD Million)
Table 6. Global Gene Therapy Media Market, by Region, 2021-2033 (USD Million)
Table 7. North America Gene Therapy Media Market, by Country, 2021-2033 (USD Million)
Table 8. North America Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 9. North America Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 10. North America Gene Therapy Media Market, by Application, 2021-2033 (USD Million)
Table 11. North America Gene Therapy Media Market, by End user, 2021-2033 (USD Million)
Table 12. U.S. Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 13. U.S. Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 14. U.S. Gene Therapy Media Market, by End user, 2021-2033 (USD Million)
Table 15. Canada Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 16. Canada Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 17. Canada Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 18. Mexico Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 19. Mexico Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 20. Mexico Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 21. Europe Gene Therapy Media Market, by Country, 2021-2033 (USD Million)
Table 22. Europe Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 23. Europe Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 24. Europe Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 25. Germany Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 26. Germany Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 27. Germany Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 28. UK Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 29. UK Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 30. UK Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 31. France Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 32. France Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 33. France Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 34. Italy Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 35. Italy Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 36. Italy Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 37. Spain Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 38. Spain Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 39. Spain Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 40. Denmark Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 41. Denmark Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 42. Denmark Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 43. Norway Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 44. Norway Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 45. Norway Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 46. Sweden Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 47. Sweden Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 48. Sweden Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 49. Asia-Pacific Gene Therapy Media Market, by Country, 2021-2033 (USD Million)
Table 50. Asia-Pacific Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 51. Asia-Pacific Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 52. Asia-Pacific Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 53. China Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 54. China Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 55. China Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 56. Japan Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 57. Japan Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 58. Japan Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 59. India Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 60. India Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 61. India Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 62. South Korea Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 63. South Korea Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 64. South Korea Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 65. Australia Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 66. Australia Gene Therapy Media Market, by Application, 2021-2033 (USD Million)
Table 67. Australia Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 68. Thailand Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 69. Thailand Gene Therapy Media Market, by Application, 2021-2033 (USD Million)
Table 70. Thailand Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 71. Latin America Gene Therapy Media Market, by Country, 2021-2033 (USD Million)
Table 72. Latin America Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 73. Latin America Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 74. Latin America Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 75. Brazil Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 76. Brazil Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 77. Brazil Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 78. Argentina Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 79. Argentina Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 80. Argentina Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 81. Middle East and Africa Gene Therapy Media Market, by Country, 2021-2033 (USD Million)
Table 82. Middle East and Africa Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 83. Middle East and Africa Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 84. Middle East and Africa Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 85. South Africa Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 86. South Africa Gene Therapy Media Market, by Application, 2021-2033 (USD Million)
Table 87. South Africa Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 88. Saudi Arabia Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 89. Saudi Arabia Gene Therapy Media Market, by Application, 2021-2033 (USD Million)
Table 90. Saudi Arabia Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 91. UAE Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 92. UAE Gene Therapy Media Market, by Application, 2021-2033 (USD Million)
Table 93. UAE Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
Table 94. Kuwait Gene Therapy Media Market, by Product, 2021-2033 (USD Million)
Table 95. Kuwait Gene Therapy Media Market, by Vector Type, 2021-2033 (USD Million)
Table 96. Kuwait Gene Therapy Media Market, by End use, 2021-2033 (USD Million)
List of Figures
Figure 1 Gene therapy media market segmentation
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validation & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot - 1
Figure 14 Competitive landscape snapshot
Figure 15 Market trends & outlook
Figure 16 PESTEL analysis
Figure 17 Porter’s five forces analysis
Figure 18 Gene therapy media market: Product outlook key takeaways
Figure 19 Gene therapy media market: Product movement analysis
Figure 20 Specialty media market, 2021-2033 (USD Million)
Figure 21 Serum-free Media market, 2021-2033 (USD Million)
Figure 22 Classical media market, 2021-2033 (USD Million)
Figure 23 Others market, 2021-2033 (USD Million)
Figure 24 Gene therapy media market: Vector type outlook key takeaways
Figure 25 Gene therapy media market: Vector type movement analysis
Figure 26 AAV production market, 2021-2033 (USD Million)
Figure 27 LV production market, 2021-2033 (USD Million)
Figure 28 Others production market, 2021-2033 (USD Million)
Figure 29 Gene therapy media market: End Use outlook key takeaways
Figure 30 Gene therapy media market: End Use movement analysis
Figure 31 Pharmaceutical and biotechnology companies market, 2021-2033 (USD Million)
Figure 32 Contract Development & Manufacturing Organizations (CDMOs) & CROs market, 2021-2033 (USD Million)
Figure 33 Research and Academic Institutes market, 2021-2033 (USD Million)
Figure 34 Regional marketplace outlook, 2025 & 2033 (USD Million)
Figure 35 Regional marketplace: Key takeaways
Figure 36 North America gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 37 Key country dynamics
Figure 38 U.S. gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 39 Key country dynamics
Figure 40 Canada gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 41 Key country dynamics
Figure 42 Mexico gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 43 Europe gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 44 Key country dynamics
Figure 45 Germany gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 46 Key country dynamics
Figure 47 UK gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 48 Key country dynamics
Figure 49 France gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 50 Key country dynamics
Figure 51 Italy gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 52 Key country dynamics
Figure 53 Spain gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 54 Key country dynamics
Figure 55 Denmark gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 56 Key country dynamics
Figure 57 Sweden gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 58 Key country dynamics
Figure 59 Norway gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 60 Asia-Pacific gene therapy media market estimates and forecast, 2021-2033 (USD Million)
Figure 61 Key country dynamics
Figure 62 Japan gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 Key country dynamics
Figure 64 China gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Key country dynamics
Figure 66 India gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Key country dynamics
Figure 68 South Korea gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Key country dynamics
Figure 70 Australia gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 Key country dynamics
Figure 72 Thailand gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 73 Latin America gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Key country dynamics
Figure 75 Brazil gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Key country dynamics
Figure 77 Argentina gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 MEA gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 79 Key country dynamics
Figure 80 South Africa gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 81 Key country dynamics
Figure 82 Saudi Arabia gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 83 Key country dynamics
Figure 84 UAE gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 85 Key country dynamics
Figure 86 Kuwait gene therapy media market estimates and forecasts, 2021-2033 (USD Million)
Figure 87 Market position analysis

Companies Mentioned

The leading players profiled in this Gene Therapy Media market report include:
  • hermo Fisher Scientific Inc.
  • artorius AG
  • erck KGaA
  • onza
  • anaher Corporation (Cytiva)
  • UJIFILM Holdings Corporation
  • P Biomedicals
  • orning Incorporated
  • AN-Biotech
  • io-Techne (R&D Systems, Inc.)
  • nVitria Inc.
  • lorabio AS
  • evvity
  • irica

Related Topics

Related Reports

U.S. Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report by Product (Media, Sera, Antibodies, Reagents & Buffers), by End-use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs), by Region, and Segment Forecasts, 2025-2033 - Product Image

U.S. Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report by Product (Media, Sera, Antibodies, Reagents & Buffers), by End-use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs), by Region, and Segment Forecasts, 2025-2033

  • Report
  • 90 Pages
  • United States
From
Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis: Focus on Therapy Type, Offering, Process, Technology, Application, and Region - Analysis and Forecast, 2023-2033 - Product Image

Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis: Focus on Therapy Type, Offering, Process, Technology, Application, and Region - Analysis and Forecast, 2023-2033

  • Report
  • 361 Pages
  • Global
From
Cell and Gene Therapy CDMO Market Size, Share & Trends Analysis Report by Phase (Pre-clinical, Clinical), Product (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), Indication (Oncology, Infectious Diseases), and Region with Growth Forecasts, 2025-2033 - Product Image

Cell and Gene Therapy CDMO Market Size, Share & Trends Analysis Report by Phase (Pre-clinical, Clinical), Product (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), Indication (Oncology, Infectious Diseases), and Region with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
U.S. Cell and Gene Therapy CDMO Market Size, Share & Trends Analysis Report by Phase (Pre-clinical, Clinical), Product (Gene Therapy, Cell Therapy, Gene-Modified Cell Therapy), Indication (Oncology, Infectious Diseases), and Growth Forecasts, 2025-2033 - Product Image

U.S. Cell and Gene Therapy CDMO Market Size, Share & Trends Analysis Report by Phase (Pre-clinical, Clinical), Product (Gene Therapy, Cell Therapy, Gene-Modified Cell Therapy), Indication (Oncology, Infectious Diseases), and Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • United States
From
U.S. Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Disease (Cancer, Infectious Diseases), By Grade (R&D, GMP), By Application, By Development Phase, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Disease (Cancer, Infectious Diseases), By Grade (R&D, GMP), By Application, By Development Phase, And Segment Forecasts, 2025 - 2033

  • Report
  • 120 Pages
  • United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.